Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Québec City, Québec, Canada.
PLoS Pathog. 2011 Dec;7(12):e1002431. doi: 10.1371/journal.ppat.1002431. Epub 2011 Dec 8.
Neuraminidase (NA) mutations conferring resistance to NA inhibitors were believed to compromise influenza virus fitness. Unexpectedly, an oseltamivir-resistant A/Brisbane/59/2007 (Bris07)-like H1N1 H275Y NA variant emerged in 2007 and completely replaced the wild-type (WT) strain in 2008-2009. The NA of such variant contained additional NA changes (R222Q, V234M and D344N) that potentially counteracted the detrimental effect of the H275Y mutation on viral fitness. Here, we rescued a recombinant Bris07-like WT virus and 4 NA mutants/revertants (H275Y, H275Y/Q222R, H275Y/M234V and H275Y/N344D) and characterized them in vitro and in ferrets. A fluorometric-based NA assay was used to determine Vmax and Km values. Replicative capacities were evaluated by yield assays in ST6Gal1-MDCK cells. Recombinant NA proteins were expressed in 293T cells and surface NA activity was determined. Infectivity and contact transmission experiments were evaluated for the WT, H275Y and H275Y/Q222R recombinants in ferrets. The H275Y mutation did not significantly alter Km and Vmax values compared to WT. The H275Y/N344D mutant had a reduced affinity (Km of 50 vs 12 µM) whereas the H275Y/M234V mutant had a reduced activity (22 vs 28 U/sec). In contrast, the H275Y/Q222R mutant showed a significant decrease of both affinity (40 µM) and activity (7 U/sec). The WT, H275Y, H275Y/M234V and H275Y/N344D recombinants had comparable replicative capacities contrasting with H275Y/Q222R mutant whose viral titers were significantly reduced. All studied mutations reduced the cell surface NA activity compared to WT with the maximum reduction being obtained for the H275Y/Q222R mutant. Comparable infectivity and transmissibility were seen between the WT and the H275Y mutant in ferrets whereas the H275Y/Q222R mutant was associated with significantly lower lung viral titers. In conclusion, the Q222R reversion mutation compromised Bris07-like H1N1 virus in vitro and in vivo. Thus, the R222Q NA mutation present in the WT virus may have facilitated the emergence of NAI-resistant Bris07 variants.
神经氨酸酶(NA)突变赋予了对 NA 抑制剂的耐药性,这被认为会损害流感病毒的适应性。出人意料的是,2007 年出现了一种奥司他韦耐药的 A/Brisbane/59/2007(Bris07)样 H1N1 H275Y NA 变体,并在 2008-2009 年完全取代了野生型(WT)株。该变体的 NA 含有额外的 NA 变化(R222Q、V234M 和 D344N),这可能抵消了 H275Y 突变对病毒适应性的不利影响。在这里,我们拯救了一株 Bris07 样 WT 病毒和 4 种 NA 突变体/回复突变体(H275Y、H275Y/Q222R、H275Y/M234V 和 H275Y/N344D),并在体外和雪貂中对它们进行了特征分析。我们使用基于荧光的 NA 测定法来确定 Vmax 和 Km 值。通过在 ST6Gal1-MDCK 细胞中的产量测定来评估复制能力。在 293T 细胞中表达重组 NA 蛋白,并测定表面 NA 活性。在雪貂中评估了 WT、H275Y 和 H275Y/Q222R 重组体的感染性和接触传播实验。与 WT 相比,H275Y 突变并未显著改变 Km 和 Vmax 值。H275Y/N344D 突变体的亲和力降低(Km 为 50 vs 12 µM),而 H275Y/M234V 突变体的活性降低(22 vs 28 U/sec)。相比之下,H275Y/Q222R 突变体的亲和力(40 µM)和活性(7 U/sec)均显著降低。WT、H275Y、H275Y/M234V 和 H275Y/N344D 重组体具有可比的复制能力,而 H275Y/Q222R 突变体的病毒滴度则显著降低。与 WT 相比,所有研究的突变均降低了细胞表面 NA 活性,其中最大的降低发生在 H275Y/Q222R 突变体中。WT 和 H275Y 突变体在雪貂中具有相似的感染性和传染性,而 H275Y/Q222R 突变体与肺病毒滴度显著降低相关。总之,Q222R 回复突变使 Bris07 样 H1N1 病毒在体外和体内的适应性降低。因此,WT 病毒中存在的 R222Q NA 突变可能促进了 NAI 耐药 Bris07 变体的出现。